Skip to content

‘Pharma Bro’ Company Vyera Settles Suit Over Drug Pricing

Martin Shkreli exits federal court in the Brooklyn, New York in 2017.

Martin Shkreli exits federal court in the Brooklyn, New York in 2017.

Photographer: Peter Foley/Bloomberg
Updated on

Vyera Pharmaceuticals LLC, the company once led by convicted “Pharma Bro” Martin Shkreli, agreed to pay as much as $40 million to resolve a federal antitrust lawsuit over a 2015 drug-pricing scandal. 

Under a settlement agreement, former Vyera Chief Executive Officer Kevin Mulleady will be barred “from almost any role at a pharmaceutical company for seven years,” Attorney General Letitia James, who led a group of states in the lawsuit, said in a statement Tuesday.